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Accepted 17 October 2014; Published online 11 December 2014AbstractObjectives: There is often substantial uncertainty about the impacts of health system and policy interventions. Despite that, randomized
controlled trials (RCTs) are uncommon in this field, partly because experiments can be difficult to carry out. An alternative method for
impact evaluation is the interrupted time-series (ITS) design. Little is known, however, about how results from the two methods compare.
Our aim was to explore whether ITS studies yield results that differ from those of randomized trials.
Study Design and Setting: We conducted single-arm ITS analyses (segmented regression) based on data from the intervention arm of
cluster randomized trials (C-RCTs), that is, discarding control arm data. Secondarily, we included the control group data in the analyses, by
subtracting control group data points from intervention group data points, thereby constructing a time series representing the difference
between the intervention and control groups. We compared the results from the single-arm and controlled ITS analyses with results based
on conventional aggregated analyses of trial data.
Results: The findings were largely concordant, yielding effect estimates with overlapping 95% confidence intervals (CI) across
different analytical methods. However, our analyses revealed the importance of a concurrent control group and of taking baseline and
follow-up trends into account in the analysis of C-RCTs.
Conclusion: The ITS design is valuable for evaluation of health systems interventions, both when RCTs are not feasible and in the
analysis and interpretation of data from C-RCTs.  2015 The Authors. Published by Elsevier Inc. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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The randomized controlled trial (RCT) is widely re-
garded as the gold standard research design for measuring
the impacts of interventions, and RCTs dominate effective-
ness research in clinical medicine.
The field of health system and policy evaluation is very
different: randomized trials are seldom carried out, despite
substantial uncertainty about the impacts of health system
interventions on the costs and outcomes of care. This isess article under the CC BY-NC-ND license (http://creativecommons.org/
325ical Epidemiology 68 (2015) 324e333What is new?
 Our findings support the position that concurrent
control groups are important, but the single-arm in-
terrupted time-series design, in which the preinter-
vention period serves as control, yielded findings
that were usually concordant with the randomized
controlled trials (RCTs).
 If data from RCTs are analyzed without taking
baseline and follow-up trends into account, our re-
sults indicate that the findings may sometimes be
misleading.
 Those who commission or conduct impact evalua-
tions of health system interventions should
routinely use graphical displays of longitudinal
data and time-series analysis methods when evalu-
ating intervention effects, whether randomization
is feasible or not.
A. Fretheim et al. / Journal of Clindue in part to practical difficulties encountered when con-
ducting randomized trials of health system interventions,
such as nationwide reforms (eg, introducing user fee ex-
emptions for pregnant women and children). Therefore,
other study designs are often used in this field. The simplest
preepost design uses single observations before and after
an intervention to evaluate whether a change occurs. How-
ever, because factors other than the intervention (eg, secular
trends) may cause an observed change (or lack of change),
this is considered a weak method [1,2]. An extension of this
approach is the single-arm interrupted time-series (ITS)
design, where multiple measurements are carried out before
and after an intervention, which can control for preinterven-
tion and postintervention trends [3e5]. The ITS method is
widely recommended for impact evaluation of system and
policy changes and has been promoted as ‘‘a particularly
strong quasi-experimental alternative to randomized de-
signs when the latter are not feasible’’ [6].
It is widely recognized that different study designs differ
in internal validity and various study designs are some-
times placed in a hierarchy [7]. In these hierarchies, ran-
domized trials are typically rated above nonrandomized
studies, including ITS studies. Most systematic reviews
published through the Cochrane Collaboration only include
randomized trials. Among the exceptions are systematic re-
views from the ‘‘Effective Practice and Organisation of
Care’’ review group, which often include nonrandomized
studies (including ITS studies) [8]. Findings from ITS
studies are, however, generally considered to have a higher
risk of bias than findings from RCTs [9]. This is based on
the logical argument that only randomization is able to
control for confounders that are not known or measured,
whereas other study designs can only control forconfounders that are known and measured [10]. Studies
have investigated the effectiveness of randomization in
limiting selection bias (and thus ensuring comparable
groups in effectiveness evaluations), but this work has
mainly focused on clinical trials and less on health system
and policy interventions [11]. Also, previous research
comparing the results from randomized trials with those
from other study designs has often lumped together many
different types of nonrandomized studies. This may be
inappropriate because all nonrandomized study designs
are not equally prone to bias.
An overview of existing reviews addressed the issue of
whether RCTs provide the same effect size and variance
as nonrandomized studies of similar policies [12]. The au-
thors reported that in many cases, the effect sizes from
RCTs differed from nonrandomized studies. Consequently,
they concluded that ‘‘policy evaluations should adopt ran-
domized designs whenever possible.’’ However, ITS ana-
lyses were not considered separately in that report.
There are few empirical data from which to draw firm
conclusions regarding the relative merits of different study
designs for effectiveness evaluations. Debates on this topic
are largely based on theoretical arguments. This is particu-
larly the case for ITS because little has been done to
compare findings from ITSs and RCTs in a systematic way.
In practice, randomized experiments of system interven-
tions are almost invariably cluster randomized trials (C-
RCTs) that randomize groups rather than individuals (eg,
clinics, hospitals, communities). We recently conducted a re-
analysis of one C-RCT and found that estimates from ITS
analyses of the intervention arm only (single-arm ITS),
and incorporating both the intervention and control groups
(controlled ITS), were concordant with the C-RCT result
[13]. Additional comparisons of the same sort would help
to determine whether those findings can be generalized.
The aim of this article was to further explore whether
ITSs yield results that differ from those of cluster random-
ized controlled trials (C-RCTs) and to identify possible
explanatory factors for such differences. Our primary
objective was to compare each trial result with the effect es-
timate based on the single-arm ITS (ie, only intervention
group data, discarding the control group). In addition, we
conducted ITS analyses incorporating data from both arms
of each trial.2. Methods
The full study protocol is found in the Appendix at
www.jclinepi.com.
2.1. Search for trials
We searched for C-RCTs of health system interventions
where data were available for a series of time points before
and after the interventions were implemented. The amount
of data had to be sufficient to allow for meaningful ITS
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and after the intervention was implemented with a mini-
mum of 50 observations per time point. In addition, we al-
lowed for a maximum of six missing time points between
the preintervention and postintervention periods (transition
period).
As a secondary analysis, we included studies with only
3e5 time points before or after the intervention.
Our main source of candidate trials was an inventory of
C-RCTs [14]. Every entry in the C-RCT inventory was
coded according to the type of intervention that was evalu-
ated. We retrieved full text reports of trials of interventions
coded as financial arrangements, delivery arrangements,
governance arrangements, or implementation strategies.
We only included trials published in 2000 or later and re-
ported in peer-reviewed publications written in English.
As the trial inventory only included trials published up to
2010, we conducted a supplementary PubMed search for
C-RCTs up to July 2012.
We concealed the results and discussion sections in the
retrieved articles using 3M Post-it notes and attempted to
remain blinded to the original results until after our ana-
lyses had been completed.
All full text reports were read by one of us (A.F.). If a
trial was deemed potentially usable for our purpose, the
corresponding author was contacted by e-mail and asked
to share the trial data file with us. If we received no
response after repeated attempts, we tried to contact one
of the coauthors.2.2. Analysis
We conducted our primary analysis on the intervention
arm of the trials only, thus yielding effect estimates that
the investigators would have found had they used a
single-arm ITS (ie, no concurrent control group) rather than
a C-RCT as their evaluation method. To the extent possible,
we conducted our analyses on the trials’ primary outcomes.
We reanalyzed the trial data using a basic segmented
regression method [15,16]:Yt5b0þ b1Timet þ b2 Interventiont þ b3
Time after interventiont þ εtHere, Yt is the dependent variable score at time t. Timet
is the value of the time variable ‘‘Time’’ at time t. ‘‘Inter-
vention’’ is the value of the level-change variable (ie,
0 before the intervention and 1 after the intervention); for
interventions that are gradually introduced, the time points
during the transition phase are set to missing. ‘‘Time after
intervention’’ is the value of the slope change variable
defined as [Time  (n1 þ 1)]  Intervention, where n1 is
the total number of time points before the postintervention
period. b0 is the intercept, b1 represents the modeled slope
during the preintervention period, b2 the level change after
the intervention, and b3 the change in slope from before toafter the intervention. εt is the error term representing the
variability not explained by the model.
We ran ordinary least squares regressions and used the
DurbineWatson test to assess the degree of first-order auto-
correlation [17]. We used the PraiseWinston method to
adjust for autocorrelation, when deemed necessary based
on the DurbineWatson test results.
We prespecified intervention transition periods (ie, the
period during which an intervention was being imple-
mented before measurement of postintervention outcomes
began) in the ITS analyses. We typically used months as
the observation period, as is often done in ITS studies in
our field [15]. However, we opted for other time points
(eg, weeks) when we judged that to be more appropriate
(ie, if there were sufficient data to allow for further disag-
gregation into more time points).
As is customary for ITS analyses, we computed two ef-
fect estimates: (1) the change in level and (2) change in
trend (slope) from before to after the intervention. To
include both effect estimates in one metric, for comparison
against the C-RCT effect estimate, we modeled the ITS es-
timate halfway through the postintervention period (ie, the
difference between the levels of the preintervention and the
postintervention regression lines halfway through the post-
intervention period; see Fig. 1).
We also conducted our ownC-RCTanalyses, to ensure that
the ITS andC-RCTestimateswere as comparable as possible,
for example, that they were based on the exact same data. In
some cases, we discarded parts of the data set to make it
amenable for time-series analysis, as specified in the Section
3. Consequently, our C-RCT estimates in some cases differ
from the estimates in the original publications.OurC-RCTef-
fect estimates were recalculated by comparing the postinter-
vention observations in the intervention and control groups,
using baseline levels for each cluster as covariates (analysis
of covariance) in a generalized estimating equation (logistic
regression using the logit link function for binary outcomes
and the log link function for count outcomes) [18]. Themodel
incorporated all datawhile controlling for clustering effects at
the sampling unit level.We used themargins command to turn
the resulting odds ratios into percentages, at populationmean
of other covariates [19,20]. Trends over timewithin the prein-
tervention or postintervention periods were not taken into ac-
count in this model.
We also conducted a controlled ITS analysis of the dif-
ference between the intervention and control groups in the
C-RCT. By subtracting the value of the outcome variable in
the control group from the corresponding value in the inter-
vention group at each time-series data point, we con-
structed a new time series of differences between the two
groups. This time series was used to calculate the difference
in slope and level changes between the intervention and
control groups.
Finally, we consulted with authors of the included
studies to consider possible explanatory factors for differ-
ences between the C-RCT and ITS findings.
Fig. 1. Example illustrating how level and trend changes were combined in one effect estimate: the difference between the level of the preinter-
vention regression line and the postintervention line halfway through the postintervention period.
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Station, TX) using the REGRESS, PRAIS, ESTAT DWAT-
SON, and XTGEE commands.
2.3. Deviation from study protocol
We did not conduct ITS analyses on patient level data. In
our previous study, such analyses added little to our main
aggregated ITS approach [13]. Also, we decided to limit
our analyses to absolute effect measures, as it proved tech-
nically difficult to estimate and compare relative effect
estimates.3. Results
We identified 524 potentially relevant trials for which
we retrieved full text reports. From these, we identified
89 as potentially usable for ITS analysis. We managed to
make contact with the majority of investigators, although
in most cases, they responded that the data were not suit-
able for our purpose, not possible to share (eg, due to pri-
vacy concerns), or no longer available. Eventually, we
received 19 data sets, of which eight met our inclusion
criteria [21e28]. One of the eight trials [22] evaluated
two interventions in two different patient groups, resulting
in a total of nine ITS vs. C-RCT comparisons.
3.1. Description of included studies
Three of the trials evaluated the impact of system
changes in health services [24,26,27]. The five remaining
studies were trials of interventions aimed at improvingpractices among midwives [21] and primary care physi-
cians [22,23,25,28]. All studies were conducted in high-
income countries. The number of observations varied
considerably across the trials, see Table 1 for further
details.
Only four trials included six or more time points before
and after the interventions were included in our main ana-
lyses. Most of the remaining studies included five time
points before and after the intervention. We assessed these
studies separately.
3.2. Main findings
An overview of the results is shown in Fig. 2. In eight of
the nine cases, the different analytical methods yielded
overlapping 95% CIs. For a complete presentation of
regression coefficients and autocorrelation statistics from
the ITS analyses, see the Appendix at www.jclinepi.com.
The four data sets with at least six time points before and
after the intervention were from the studies by Wright et al.
[27], Fretheim et al. [28], Goodacre et al. [24], and Foy
et al. [23].
The graphical presentation of the study by Wright
(Fig. 3) convincingly displays an immediate and substantial
increase in physicians’ registration of clinical problems in
the medical records, following the introduction of an elec-
tronic alert system. No concurrent change among physicians
in the control group is visible. The calculated effect esti-
mates were very similar across the different methods
(Fig. 2), but the observed waning of effect over time
(Fig. 3) would not have been detected in a conventional
aggregated C-RCT analysis. According to the study authors
Table 1. Included trials
Trial (setting) Intervention Main outcome Events (time points)a
Wright et al. [27] (clinics affiliated
with an academic medical
center, MA, USA)
A clinical alerting system that uses
inference rules to notify
providers of undocumented
problems
The number of study problems
addedb
13,551 Problems added
(26 before and after)
Fretheim et al. [28] (primary
care practices, Norway)
Educational outreach visits,
computer-based decision
support and reminders, and
patient educational material
Prescribing of low-dose diuretics
as first-line antihypertensive
medication (proportion)
966 Prescriptions for low-dose
diuretics of 9,301
antihypertensive prescriptions
(12 before and after)
Goodacre et al. [24]
(acute hospitals, UK)
Establishment of chest pain unit Chest pain attendances resulting
in admission (proportion)
48,115 Admissions of 82,190
attendances (11 before
and after)
Foy et al. [23] (primary care
practices, England, UK)
Brief educational messages added
to article and electronic primary
care practice laboratory test
reports
HbA1c below 6.35% (proportion) 11,882 Tests below 6.35%, of
68,007 tests (24 before and
35 after)
Flottorp et al. [22] (primary
care practices, Norway)c
Patient educational material,
computer-based decision
support and reminders, an
increase in the fee for telephone
consultations, and interactive
courses (for urinary tract
infection or sore throat)
Use of antibiotics, for urinary
tract infection or sore throat
(proportion)
Sore throat: 8,065 prescriptions of
16,939 consultations; urinary
tract infection: 4,418
prescriptions of 9,887
consultations (5 before and
after)
Kerse et al. [26] (residential
care homes, New Zealand)
Residential care staff, using
existing resources, implemented
systematic individualized fall-
risk management for all
residents using a fall-risk
assessment tool, high-risk logo,
and strategies to address
identified risks
Number of residents sustaining
a fall, total falls
2,002 Falls (5 before and
12 after)
Cheyne et al. [21] (maternity
units, Scotland, UK)
Use of an algorithm by midwives
to assist their diagnosis of
active labor
Use of oxytocin for augmentation
of labor (proportion)
736 Uses of oxytocin in 2,195
births (5 before and 9 after)
Haynes et al. [25] (primary care
physicians, Ontario, Canada)
McMaster PLUS, an internet-
based addition to an existing
digital library, with quality- and
relevance-rated medical
literature to physicians
Number of logins per month
per user
3,841 Logins (3 before and
12 after)
a The total number (count) of outcomes included in our analyses and the number of time points included in the interrupted time series ana-
lyses, preintervention and postintervention periods, respectively.
b This was a prespecified secondary outcome. We used this because the main outcome (‘‘acceptance of the alert’’) was not amenable for time-
series analysis (no baseline data).
c In this trial, half the participating practices received interventions to implement guidelines for urinary tract infection and the other half
received interventions to implement guidelines for sore throat, serving as controls for each other.
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line behavior is that the number of unregistered clinical
problems had accumulated, so there were more problems
to register at the beginning of the intervention period.
In the study by Fretheim, an immediate increase in the
prescribing of recommended first-line medication (low-
dose diuretic for hypertension) was observed in the inter-
vention group when the quality improvement intervention
was implemented (Fig. 3). The effect estimates were
concordant across methods (Fig. 2).
In the study by Goodacre, we discarded data from the
last month before the start of the intervention and from
the first month after, because of missing data from these
months. The graphical presentation (Fig. 3) shows that
among patients presenting at the emergency room, therewas a slight increase in the proportion admitted to hospital
in the intervention group during the baseline period,
whereas the control hospitals showed a minor trend in the
opposite direction. After dedicated chest pain units were
introduced, there was a small immediate reduction in ad-
missions, followed by a downward trend in the intervention
hospitals. Neither the baseline difference in trends nor the
change in trend after the intervention could be detected in
the C-RCT analysis, which resulted in a highly uncertain
estimate of 1.5 percentage points (95% CI: 2.7, 5.8). In
contrast, the single-arm ITS and the controlled ITS ana-
lyses found a clear impact of the intervention: 5.2 per-
centage points (95% CI: 9.0, 1.3) and 8.1
percentage points (95% CI: 14.6, 1.6), respectively.
The 95% CIs from all three analyses overlap.
Fig. 2. Effect estimates expressed as absolute differences (95% CIs).
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by Foy revealed that the proportion of patients with dia-
betes who had achieved an HbA1C goal of 6.35% stopped
decreasing when brief educational messages were intro-
duced to physicians (see Fig. 3). Surprisingly, the same
pattern occurred among physicians who were not exposed
to this intervention. Although the single-arm ITS yielded
a discrepant result, the controlled ITS produced a result
similar to the C-RCT.
The four data sets that included five time points in one or
both periods were from the studies by Flottorp et al. [22],
Kerse et al. [26], and Cheyne et al. [21]. Not surprisingly,
the effect estimates based on ITS analyses of such few data
points were imprecise (ie, wide 95% CIs, see Fig. 2).
The findings from the two data sets from the study by
Flottorp were concordant across the various analytical
methods (ie, the CIs overlapped, see Fig. 4). However,the imprecise effect estimates from the ITS analyses limit
the usefulness of the comparison.
The graphical presentation of the Kerse data set raises
several questions. Why did the rate of falls in the residential
homes increase so rapidly during the baseline period? Why
did the increase in falls cease in the control group when the
intervention was launched in the intervention group but
continue to increase in the intervention group? Why did
the rate of falls start to decrease in the intervention group
several months later? We do not know the answers to these
questions. Nonetheless, a simple, conventional comparison
of changes from before to after the intervention, as is usu-
ally done in C-RCT analyses, reveals none of the confusing
underlying dynamics in the occurrence of study outcomes
and would be misleading. In this case, breaking the data
down into shorter periods offers advantages in drawing in-
ferences from the study. In their original report, the authors
presented a simple graph showing the initial rise and subse-
quent reduction in fall rate associated with the intervention
and proposed several possible explanations [26].
The graph illustrating the findings from the study by
Cheyne shows a high degree of variation in the proportion of
deliverieswith oxytocin from1month to the next (Fig. 4). This
probably reflects random variation due to low numbers of pa-
tients (see Table 1). Again, comparing the C-RCT estimate
with the ITS estimates is of limited use because of the wide
CIs around ITS estimates (see Fig. 2).
Finally, we included one study with only three preinter-
vention time points: the trial by Haynes et al. of an Internet-
based medical literature service for physicians. The
graphical presentation shows wide variation of rates across
time points (Fig. 5), likely due to the low number of events
per month (see Table 1) and apparently diverging trends in
the two groups in the postintervention period. The high
variability and the few time points mean that time-series
analysis on these data is unlikely to yield reliable results.
Nevertheless, the results were relatively consistent across
the different analyses (see Fig. 2).4. Discussion
We identified eight C-RCTs of health system interven-
tions where the available data enabled us to use time-series
methods to estimate the effect of the intervention. However,
only four of the trials had sufficient data to allow for six or
more time points before and after the intervention, which
we considered a minimum threshold for reliable results.
The findings were largely concordant, yielding similar re-
sults across different analytical methods. However, our ana-
lyses revealed limitations with both the conventional
approach to analyzing C-RCTs and with the ITS approach.
These findings may have implications for the design of
future impact evaluations of health system interventions.
First, the value of having a concurrent control group was
clearly shown in the analyses based on the trial by Foy et al.
Fig. 3. Linear regression of preintervention andpostintervention time series, fromstudieswith aminimumof six timepoints before and after intervention.
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similar in the intervention and control groups, we would
have been misled to believe that the intervention was effec-
tive. Thus, the single-arm ITS analysis did not provide a
valid effect estimate in this case. Two common threats to
the validity of single-arm ITS analyses are ‘‘history’’ (ie,
cointerventionsd‘‘the possibility that forces other than
the treatment under investigation influenced the dependent
variable at the same time when the intervention was intro-
duced’’) and ‘‘instrumentation’’ (ie, changes in how an
outcome is being recorded at the same time as an interven-
tion is being implemented) [6]. We have not been able to
identify a plausible explanation as to why both the interven-
tion and control groups changed simultaneously when the
intervention was implemented for the study by Foy. How-
ever, the benefits of a control group in detecting such anom-
alous effects are clear, and the use of control groups is to be
recommended whenever possible when assessing the
effects of health system interventions.
Second, our analyses of the trials by Goodacre et al.
[24], Wright et al. [27], and Kerse et al. [26] demonstrate
how conventional C-RCT analysis may conceal important
dynamics in the preintervention and the postinterventionperiods. The most striking example is the Kerse trial.
Notable changes that took place during both the baseline
and postintervention periods would not have been noticed
without disaggregating the data sets into time series. Such
dynamics are of key importance in understanding the
effects over time and should trigger further qualitative
exploration. The Goodacre and the Wright data illustrate
the same phenomenon, although in a less striking way:
important information may be lost when changes within
the preintervention and postintervention periods remain un-
explored; such exploration is usually not done in C-RCT
analyses but should be strongly recommended.
Third, our findings support the notion that fewer than six
time points in the preintervention and postintervention
periods are probably too few for reliable ITS analyses.4.1. Strengths and weaknesses of the study
Despite a thorough search for eligible trials, we ended
up with a small number of data sets. Nevertheless, we
believe we have identified some key issues that are impor-
tant to consider when impact evaluations of health system
interventions are conducted and interpreted. Although ITS
Fig. 4. Linear regression of preintervention and postintervention time series, from studies with five time points per period.
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was not always the case and these findings should be
considered suggestive until more data are available. Unfor-
tunately, it may not be possible to predict in advance when
a control group is necessary to avoid misleading findings
from a single-arm ITS study, as was the case for one of
the trials included in this study.
Our extensive effort to search for and retrieve trials for our
studymeans that we probably have identifiedmost of the rele-
vant and accessible studies. To expand the number of trials, we
could have included a broader range of interventions,
including studies from other fields than health systems and
health policy research. For example, trials conducted in the
fields of economics, education, social welfare, and develop-
ment might have provided relevant data for the exploration
of the relativemerits of the various study designs. Futurework
may determine if our results are replicated in these fields.
Our ITS analysesmaynot represent a fair comparisonwith
the C-RCTs, for two reasons. First, our ITSs contain fewer
time points than typically recommended for these types of
studies, and results may be less stable than ITS analyses with
long baseline series. Second, we used linear regressionmodeling in all our ITS analyses, but in some cases, other
models (eg, quadratic curves) may fit the data better.4.2. Implications
Our findings support the position that concurrent control
groups are important when trying to evaluate the effectiveness
of health system interventions; failure to use control groups
can sometimes lead to erroneous inference about intervention
effects. On the other hand, the single-arm ITS design, where
the preintervention period serves as control, yielded findings
that were mostly consistent with controlled analyses. Of note,
if data from RCTs are analyzed without taking into account
trends over time, we have shown that the findings may also
sometimes be misleading. Thus, those who commission or
conduct impact evaluations of health system interventions
should routinely use graphical displays of longitudinal data
and time-series analysismethods in evaluating intervention ef-
fects whether randomization is feasible or not.
The objective of our study was to compare different
evaluation methodsdnot to reassess or replicate previously
published effect estimates. In general, our C-RCT estimates
Fig. 5. Linear regression of preintervention and postintervention time series, from studies with three data points before the intervention.
332 A. Fretheim et al. / Journal of Clinical Epidemiology 68 (2015) 324e333are in agreement with the results from the original C-RCT
publications. One exception is the Haynes et al. trial where
we, contrary to the original authors, found no convincing
effect. For our analyses, we discarded a large part of the
original data set to enable an ITS analysis, which probably
explains the discrepancy.5. Conclusion
ITS design is a valuable approach in the evaluation of
health systems interventions, both when RCTs are not
feasible and in the analysis and interpretation of data from
randomized trials.Acknowledgments
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